Skip to content
Disclosery

13F-HR filed by Catalio Capital Management, LP

Catalio Capital Management, LP filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 41 holding rows worth $478,704,496.

Accession
0001958125-26-000003
Filer
CIK 1958125
Filed
2026-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2026

A holdings report, 41 entries on the cover page, a total value of $478,704,496 stated on the cover page (in dollars after the unit check, H1), rows summing to $478,704,496 with VALUE read as dollars as filed, 13F file number 028-25237. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
DIANTHUS THERAPEUTICS INC252828108COM560,308$47,021,047dollars as filed
BRIDGEBIO PHARMA INC10806X102COM432,014$32,081,360dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR129,111$29,531,559dollars as filed
Bristol-Myers Squibb Company110122108COM420,727$25,517,093dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM1,043,670$24,380,131dollars as filed
Gilead Sciences,Inc.375558103COM163,905$22,843,440dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock409,031$21,564,114dollars as filed
DEFINIUM THERAPEUTICS INC24477V105COM SHS1,037,984$19,617,898dollars as filed
SOLENO THERAPEUTICS INC834203309COM577,808$19,345,012dollars as filed
Boston Scientific Corporation101137107COM299,318$18,782,205dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM850,797$17,824,197dollars as filed
INCYTE CORP COM45337C102Stock182,101$17,139,346dollars as filed
CYTOKINETICS INC23282W605COM NEW215,501$14,203,671dollars as filed
NATERA INC COM632307104Stock70,907$14,180,691dollars as filed
CORVUS PHARMACEUTICALS INC221015100COM891,933$13,048,980dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY255,379$12,309,268dollars as filed
MINERALYS THERAPEUTICS INC603170101COM439,041$11,893,621dollars as filed
EDWARDS LIFESCIENCES CORP COM28176E108Stock144,607$11,580,129dollars as filed
VERADERMICS INC922967104COMMON STOCK173,582$10,961,703dollars as filed
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock722,784$10,032,242dollars as filed
HEARTFLOW INC42238D107COM403,588$9,819,296dollars as filed
KALVISTA PHARMACEUTICALS INC483497103COM426,551$8,586,472dollars as filed
UNIQURE NVN90064101SHS491,116$8,029,747dollars as filed
DISC MEDICINE INC COM254604101Stock122,978$7,863,213dollars as filed
SEPTERNA INC COM81734D104Stock294,360$7,073,471dollars as filed
ABIVAX SA-00370M103SPONSORED ADS47,193$5,254,941dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock282,954$5,129,956dollars as filed
ELEDON PHARMACEUTICALS INC28617k101COM1,639,816$5,050,633dollars as filed
KARYOPHARM THERAPEUTICS INC48576U205COMMON STOCK897,709$5,000,239dollars as filed
SUPERNUS PHARMACEUTICALS868459108COM62,019$3,205,762dollars as filed
PROTARA THERAPEUTICS INC74365U107COM STK580,024$3,021,925dollars as filed
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK247,767$2,752,691dollars as filed
NEWAMSTERDAM PHARMA CO NVN62509109COMMON STOCK83,554$2,674,564dollars as filed
TYRA BIOSCIENCES INC90240B106COMMON STOCK67,285$2,577,016dollars as filed
IMMUNOCORE HLDGS PLC ADS45258D105ADR84,352$2,543,213dollars as filed
FRACTYL HEALTH INC35168W103COM5,491,866$2,514,176dollars as filed
HYPERFINE INC44916K106Common Stock1,320,041$1,425,644dollars as filed
METAGENOMI THERAPEUTICS INC59102M104COM528,993$708,851dollars as filed
ATAIBECKLEY INC04650F101COM SHS196,858$696,877dollars as filed
FAETH THERAPEUTICS INC81728A207COM NEW14,718$463,911dollars as filed
OUTSET MED INC690145206COM NEW118,279$454,191dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001958125-26-000003this filing2026-05-15acceptance time not in the bulk data set